Entering text into the input field will update the search result below

Myriad Genetics (NASDAQ:MYGN) says the U.S. Supreme Court has agreed to hear the Association for...

Nov. 30, 2012 4:35 PM ETMyriad Genetics, Inc. (MYGN) StockMYGNBy: David Yelle, SA News Editor1 Comment

Myriad Genetics (NASDAQ:MYGN) says the U.S. Supreme Court has agreed to hear the Association for Molecular Pathology's case against MYGN. The Supreme Court will review an earlier decision by the U.S. Court of Appeals for the Federal Circuit that ruled in favor of the drug developer, declaring the company's composition of matter claims covering isolated DNA of the BRCA 1 and BRCA 2 genes are patent-eligible.

Recommended For You

About MYGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MYGN--
Myriad Genetics, Inc.